Novartis AgNVS
Price (close)
$160.21
Market cap
$305.7B
P/E
21.9x
Revenue (FY)
—
Net income
$14.0B
Dividend yield
2.98%
1-year total return
25.5%
Net margin
—
Revenue growth
—
Debt / equity
—
What Novartis Ag does.
Novartis is a medicines company that researches, develops, manufactures, distributes and sells pharmaceutical products. Its core therapeutic areas are cardiovascular, renal and metabolic; immunology; neuroscience; and oncology. It is headquartered in Basel, Switzerland, and sells its products in approximately 120 countries.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net income | $8.1B | $24.0B | $7.0B | $14.8B | $11.9B | $14.0B |
| Free cash flow | $12.4B | $14.0B | $13.3B | $13.4B | $16.3B | $17.6B |
More on NVS.
- Novartis Ag summary
- Novartis Ag financial statements
- Novartis Ag key metrics
- Novartis Ag health scores and style box
- Novartis Ag earnings
- Novartis Ag dividends
- Novartis Ag valuation
- Novartis Ag ownership and insiders
- Novartis Ag peers
Figures from Novartis Ag's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.